Synthesis and Activity of Analogues of SB-219383: Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase

JOHN M. BERGE; NIGEL J. P. BROOM; CATHERINE S. V. HOUGE-FRYDRYCH; RICHARD L. JARVEST; LUCY MENSAH; DAVID J. MCNAIR; PETER J. O'HANLON; ANDREW J. POPE; STEPHEN RITTENHOUSE

doi:10.7164/antibiotics.53.1282

JOHN M. BERGE, NIGEL J. P. BROOM, CATHERINE S. V. HOUGE-FRYDRYCH, RICHARD L. JARVEST, LUCY MENSAH, DAVID J. MCNAIR, PETER J. O'HANLON, ANDREW J. POPE, STEPHEN RITTENHOUSE

著者情報

ジャーナルフリー

2000 年 53 巻 11 号 p. 1282-1292

DOI https://doi.org/10.7164/antibiotics.53.1282

詳細

抄録

SB-219383 is a naturally occurring antibiotic, which acts by inhibition of tyrosyl tRNA synthetase. Semi-synthetic derivatives of SB-219383 were prepared with the objective of elucidating the key features required for inhibition of tyrosyl tRNA synthetase in order to improve the antibacterial activity. Some ester and amide derivatives as well as monocyclic analogues exhibited sub-nanomolar inhibitory activity against tyrosyl tRNA synthetase.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）